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We study the causal effect of winning an Oscar Award on an actor
or actress’s survival. Does the increase in social rank from a performer
winning an Oscar increase the performer’s life expectancy? Previous
studies of this issue have suffered from healthy performer survivor
bias, that is, candidates who are healthier will be able to act in more
films and have more chance to win Oscar Awards. To correct this
bias, we adapt Robins’ rank preserving structural accelerated failure
time model and g-estimation method. We show in simulation studies
that this approach corrects the bias contained in previous studies.
We estimate that the effect of winning an Oscar Award on survival is
4.2 years, with a 95% confidence interval of [−0.4,8.4] years. There is
not strong evidence that winning an Oscar increases life expectancy.
1. Introduction. Does an increase in a social animal’s social “rank” cause
the animal to live longer? This question has been studied extensively in both
nonhuman primates and humans. Animals with social ranks that experi-
ence more stress have been shown to experience adverse adrenocortical, car-
diovascular, reproductive, immunological, and neurobiological consequences
[Sapolsky (2005)]. Redelmeier and Singh (2001) studied the impact of so-
cial rank on lifetime in an intriguing context: among Hollywood actors and
actresses, does winning an Oscar Award (Academy Award) cause the ac-
tor’s/actress’s expected lifetime to increase? In Redelmeier and Singh’s most
emphasized comparison (the one cited in their abstract), they stated that
life expectancy was 3.9 years longer for Oscar Award winners than for other
less recognized performers and that this difference corresponded to a 28%
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mortality rate reduction for winners compared to less recognized perform-
ers (95% CI: 10% to 42%). In an interview, Dr. Redelmeier stated, “Once
you’ve got that statuette on your mantel place, it’s an uncontested sign of
peer approval that nobody can take away from you, so that any subsequent
harsh reviews leave you more resilient. It doesn’t quite get under your skin.
The normal stresses and strains of everyday life do not drag you down.”
[Associated Press Story, February 26 (2005)].
In Redelmeier and Singh’s analysis emphasized in their abstract, they fit
a Cox proportional hazards model with whether a performer ever wins an
Oscar Award in his or her lifetime treated as a time-independent covariate
and survival measured from the performer’s date of birth. Sylvestre, Huszti
and Hanley (2006) pointed out that this analysis suffers from immortal time
bias—for a winner, the time before winning is “immortal time.” In other
words, performers who live longer have more opportunities to win Oscar
Awards. To eliminate immortal time bias, Sylvestre et al. fit a Cox pro-
portional hazards model with winning status treated as a time-dependent
covariate and survival measured from a performer’s date of first nomination
(Redelmeier and Singh also fit one time-dependent covariate model with
survival measured from the performer’s date of birth). Sylvestre et al. esti-
mated that winning an Oscar Award had a positive effect on lifetime, but
the estimated effect was not significant. Although a valuable step forward,
Sylvestre et al.’s analysis still suffers from healthy performer survivor bias:
Candidates who are healthier will be able to act in more films and have
more chances to win Oscar Awards. We provide a more detailed description
of healthy performer survivor bias in Sections 2 and 3.
In this paper we adapt James Robins’ rank preserving structural accel-
erated failure time model with g-estimation [Robins (1992); Robins et al.
(1992)] to eliminate healthy performer survivor bias; it also eliminates im-
mortal time bias, which can be seen as one aspect of healthy performer
survivor bias. Our analysis is based on the assumption that the winner of
each award is selected randomly among the nominees conditional on age at
time of nomination, number of previous nominations and number of pre-
vious wins. We first show in a simulation study the potential for healthy
performer survivor bias to make inferences from Cox models, with or with-
out time-dependent covariates, incorrect, and then show that g-estimation
provides correct inferences. We then analyze the effect of winning an Oscar
on life expectancy using g-estimation.
Our study also contributes to the debate that high socio-economic sta-
tus is associated with good health and long life. Famous examples are the
Whitehall studies of British civil servants; see Reid et al. (1974), Marmot,
Rose and Hamilton (1978), Marmot, Shipley and Rose (1984), Marmot et
al. (1991) and Ferrie et al. (2002). Recently, Rablen and Oswald (2008)
studied the causal effect of winning a Nobel Prize on scientists’ longevity.
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Correcting for potential bias, they estimated that winning the Nobel Prize,
compared to merely being nominated, is associated with between 1 and 2
years of extra longevity. Abel and Kruger (2005) studied the longevity of
Baseball Hall of Famers compared to the other players. They concluded that
median post-induction survival for Hall of Famers was 5 years shorter than
for noninducted players, which does not support the role of celebrity on
longevity.
The rest of our paper is organized as follows: Section 2 discusses previous
methods and their biases and presents a simulation study that documents
these biases, Section 3 describes the rank preserving structural failure time
model and g-estimation, Section 4 analyzes the Oscar Award data and Sec-
tion 5 provides conclusion and discussion.
2. Existing methods and biases.
2.1. Background for Oscar Awards. The Oscar Awards are the most
prominent and most watched film awards ceremony in the world. They are
presented annually by the Academy of Motion Pictures Arts and Sciences.
We will focus on the awards in four categories—Best Lead Actor, Best Lead
Actress, Best Supporting Actor, and Best Supporting Actress. The annual
awards selection process is complex, but the brief schedule is as follows: In
December, the Academy compiles a list of eligible performers for an award.
In January, all Academy members nominate five performers in each of the
four categories (Best Lead Actor, Best Lead Actress, Best Supporting Ac-
tor, Best Supporting Actress). In February, nominations for each performer
are tabulated, and the top five are publicly identified as nominees for each
category. Then all Academy members vote for one out of five nominees, and
the winner is the one who gets the most votes.
2.2. Previous work. Redelmeier and Singh (2001) compiled a list of all
nominees for the Oscar Awards from 1929 to 2000 (72 years). They also
matched each nominee to a cast member who performed in the same film as
the nominee and was the same sex and born in the same era as the nominee.
Redelmeier and Singh’s analysis was based on comparing 235 Oscar winners
to 527 nonwinning nominees, and 887 performers who were never nominated
(controls). In their primary analysis, survival was measured from perform-
ers’ dates of birth.1 In most of Redelmeier and Singh’s analyses, they used
1Redelmeier and Singh also considered survival from the day each performer’s first film
was released, each performer’s 65th birthday (excluding performers who died before 65),
and each performer’s 50th birthday (excluding performers who died before 50). As noted
by Sylvestre, Huszti and Hanley (2006), all of these methods of measuring time-zero suffer
from immortal time bias.
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the winner status as a fixed-in-time covariate, that is, a performer would
be considered a winner throughout the study if he or she won an Oscar
Award at least once in his or her lifetime. Kaplan–Meier curves showed
that life expectancy was 3.9 years longer for winner than for controls, and
3.5 years longer for winners than for nonwinning nominees. In Cox propor-
tional hazards models with no adjustment for other covariates, winning was
estimated to reduce mortality by 28% compared to controls and by 26%
compared to nonwinning nominees, with lower 95% confidence limits for
both comparisons greater than 0%, suggesting that winning an Oscar has
a beneficial effect on lifetime. Adjustment for demographic and professional
factors yielded similar results, with lower confidence limits for the mortality
reduction due to winning remaining above 0%. Redelmeier and Singh con-
sidered one Cox proportional hazard model that used the winner status as
a time-dependent covariate, that is, an Oscar Award winning performer is
treated as a winner only after he or she won an Award. This model estimated
a mortality rate reduction of 20% for winners vs. controls, with a lower 95%
CI limit of 0%.
Sylvestre, Huszti and Hanley (2006) pointed out that analyses that treat
winner status as a fixed in time covariate credit the winners’ lifetime before
winning toward survival subsequent to winning. These “immortal” years will
cause bias in the estimate of the causal effect of winning. We will focus on
Sylvestre et al.’s method for correcting this bias in comparing winners to
nonwinning nominees. Sylvestre et al. used a Cox proportional hazard model
that differed in two ways from Redelmeier and Singh’s primary analyses:
(1) winning was treated as a time-dependent covariate, an Oscar Award
winning performer only becomes a winner after he or she wins an award
(as noted above, Redelmeier and Singh also considered this approach in
one of their analyses); (2) a performer was only part of the risk set once
he or she was first nominated. Using this model, Sylvestre et al. estimated
a mortality rate reduction of 18% for winners vs. nonwinning nominees with
a 95% CI of −4% to 35%. Thus, this model estimates that winning an
Oscar has a beneficial effect on lifetime, but there is not strong evidence
for a beneficial effect. Note that Sylvestre et al. used an updated data set
compared to Redelmeier and Singh’s; Sylvestre et al. considered a selection
interval for Oscar Awards from 1929 to 2001 (73 years) with 238 winners and
528 nonwinning nominees. Sylvestre, Huszti and Hanley (2006) also used the
survival analysis method suggested by Efron (2002) and did an analysis with
a binomial logistic regression model. Death in each year of a performer’s life
was treated as a Bernoulli random variable and regressed on covariates such
as winning status, age of nomination, and calendar year of nomination. This
model yielded a similar result as Sylvestre et al.’s Cox proportional hazards
model analysis. The results from previous studies are listed in Table 1.
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Table 1
Winners vs. nominees
Reduction in
mortality rate
Type of analysis Status Time-zero (95% CI) (%)
PH1 Static3 Birthday 23 (3 to 39)
PH Dynamic4 Birthday 11 (−12 to 30)
PH Dynamic Nomination day 18 (−4 to 35)
PY2 Dynamic Nomination day 18 (−4 to 36)
Notes: These results are based on the updated data set in Sylvestre, Huszti and Hanley
(2006). The first row is the Cox model without adjustment for any covariates; the second
row is the Cox model with winning status as a time-dependent covariate and with sex and
year of birth as time-independent covariates; the third row is the Cox model with the same
covariates as the second row, but with nomination day as time-zero; the fourth row is the
binomial logistic regression model with sex, age, and calendar year as covariates. The first
two rows are from Redelmeier and Singh’s analysis (using Sylvestre et al.’s updated data
set), and the last two rows are from Sylvestre et al.’s analysis.
1PH stands for Cox proportional hazard model.
2PY stands for performer years analysis, which is the binomial logistic regression model
described above.
3Static status treats the winning status as a fixed-in-time covariate.
4Dynamic status treats the winning status as a time-dependent covariate.
2.3. Healthy performer survivor bias. Previous studies have suffered from
healthy performer survivor bias, that is, candidates who are healthier will
be able to act in more films and have more chances to win Oscar Awards.
One aspect of healthy performer survivor bias is immortal time bias, that
is, candidates will have more chances to win Oscar Awards if they live longer.
When a performer is classified as a winner throughout the study, regardless
of when the performer wins the award, there are unfair comparisons between
winners and nonwinning performers who died before the winner won the
award. As an example, consider Henry Fonda and Dan Dailey, who were
both first nominated for an Oscar Award at the age of 35 but did not win
in their first nominations. Fonda first won an Oscar at age 77 and died four
months after, while Dailey never won an Oscar and died at age 64. Fonda
lived 13 years beyond the age of Dailey’s death before winning an Oscar.
It is not fair to consider the 13 years before Fonda won his Oscar as being
affected by winning.
To correct for immortal time bias, Sylvestre et al. used a Cox proportional
hazard model with the winning status as a time-dependent covariate. In this
model, the survival comparison between a winner and a nonwinning nominee
starts appropriately only at the time the winner wins.
Although Sylvestre et al.’s analysis was an important advance in that
it corrects for immortal time bias, it still suffers from other aspects of the
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healthy performer survivor bias. Winning an Oscar Award is an indicator
of being healthy. In Sylvestre et al.’s analysis, the risk set at a given age
consists of those performers who have been nominated by that age. Among
these performers, those who are healthy at the given age have had more
opportunities to perform and to win an Oscar. These healthy performers
are also more likely to live longer. Since having won an Oscar is associated
with survival in a risk set even if winning has no causal effect on survival,
there is the potential for bias.
As an example consider Jack Palance and Arthur O’Connell who were first
nominated for Oscars but did not win at ages 34 and 48, respectively. Palance
won an Oscar at age 73, while O’Connell never won an Oscar. Palance was
an active actor when he was in his 70s, acting in ten films in his 70s, and
lived to be 87. On the other hand, O’Connell was stricken with Alzheimer’s
disease by the time he turned 70 and by the time of his death at age 73, he
was appearing solely in toothpaste commercials (www.imdb.com). The fact
that Palance lived longer than O’Connell in the risk set that started at age
73 after Palance’s first win is not likely due to the effect of winning but to
the healthy performer survivor bias.
One way of attempting to control for healthy performer survivor bias is
to condition on (control for) confounders in the Cox model. In particular,
nomination history is a confounder because it is a strong risk factor for
subsequently winning on Oscar Award (indeed, it is necessary) and for mor-
tality, since sick individuals do not get nominated. Previous studies did not
condition on nomination history and thus suffered from confounding bias.
However, even if we condition on nomination history, as well as past age
and Oscar wins, and there are no other confounders besides these variables,
the time-dependent Cox model can be biased if Oscar winning affects future
nominations [Robins (1986, 1992)]. It is substantively plausible that previ-
ous Oscar winning affects future nomination (even under the stronger null
hypothesis that neither nomination nor winning affects health). The effect
could go in either direction. For example, among two subjects with the same
nomination history, only one of whom won before, the winner would have
a higher probability of being renominated if increased fame coming from
previously winning results in an increased chance of nomination per film, all
else being equal. On the other hand, the winner would have a lower proba-
bility of being renominated if nominators felt those who have not won before
are more deserving of a chance to win.
To understand the bias in the Cox analysis when previous Oscar winning
affects future nomination, suppose a previous winner has a higher probability
of being renominated, all else being equal. Then one would expect that
among the nominees in a given year with same past nomination histories,
the previous winners would be less healthy than the previous nonwinners,
since the nonwinners might have had to be in a large number of movies in
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Table 2
Performers’ age pattern
Sick age Death age
Group 1 60 70
Group 2 70 80
Group 3 80 90
the previous year to get nominated for one of them, while for the winner it
often would suffice to be in just one. But only a healthy person could be in
many movies in one year. Note that this bias persists even if we had data on
the number of movies performed in each year and adjusted for this variable
as well as nomination.
2.4. Simulation studies. To illustrate the potential of previous studies of
survival in Oscar Award winning performers to suffer from healthy performer
survivor bias, we conducted a simulation study.
We first assigned a lifetime for each performer and a time at when the
performer became sick. Then for each year, we randomly pick nominees
from performers who are still alive and healthy, and randomly select one
of them as the winner. Hence, winning an award does not have any effect
on prolonging performers’ lifetime, because lifetime is predetermined before
deciding who wins the awards. If a method shows an effect of winning over
repeated simulations from this setting, it is biased.
For each year between 1830 and 1999, we simulated five performers being
born. Each performer was randomly selected to have one of the three age
patterns shown in Table 2.
For each year from 1927 to 2004, we have one award and we select 5
nominees from those performers who are still alive and healthy. The details
are that we select two nominees from the age group 30–39, and one from
70–79, selecting randomly among healthy performers in those age groups.
We also select two nominees from the age group 60–69, but with different
selection probabilities for healthy performers in this age group. For age group
60–69, the selection weight for a healthy candidate is in Table 3.
Table 3
Selection weight for age 60–69
Previous winner Previous nonwinner
Group 1 0 0
Group 2 8 1
Group 3 9 7
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In this sense, for age group 60–69, winning in the past increases the chance
to be selected as a nominee, and previous nonwinners tend to be healthier
than previous winners (i.e., in Group 3 rather than in Group 2). This corre-
sponds to the fact that previous nonwinners might have had to be in a large
number of movies in the previous year to get nominated for one of them,
while for the previous winners it often would suffice to be in just one film to
get nominated. Consequently, nominated previous winners tend to be less
healthy than nominated previous nonwinners, because nominated previous
nonwinners tend to be very healthy to be able to act in many films.
Nominees from different age groups have a different probability to be
selected as the winner, with older nominees having a better chance. The
winning probability also depends on the nomination history and winning
history. Let 130, 160, and 170 be the indicators of current nomination age
group 30–39, 60–69, and 70–79, respectively. Let N30, N60, N70 be the num-
ber of previous nominations in the age group 30–39, 60–69, and 70–79, re-
spectively. Let W30, W60, W70 be the number of previous wins in the age
group 30–39, 60–69, and 70–79, respectively. The winning probability for
each nominee in a given year is calculated as
P (Ai = 1|Ni,Ai)
= exp(0.5 ∗ 1i30 + 1
i
60 + 2 ∗ 1
i
70
+ 0.5(N i30 +N
i
60 +N
i
70 +W
i
30 +W
i
60 +W
i
70))/ 5∑
j=1
exp(0.5 ∗ 1j30 + 1
j
60 + 2 ∗ 1
j
70
+ 0.5(N j30 +N
j
60 +N
j
70 +W
j
30 +W
j
60 +W
j
70)).
We choose these coefficients to magnify the healthy performer survivor bias.
In our simulation setting, death ages are determined before winning, thus
winning has no causal effect on lifetime. Therefore, for the null hypothesis
that there is no treatment effect of winning an Oscar Award on an actor’s
survival, the p-values should be uniformly distributed between 0 and 1, and
the mean of p-values should be around 0.5. If the mean of p-values from
a method is much smaller than 0.5, then the method is biased.
The results from 1000 simulations are shown in Table 4 and histograms
of p-values can be found in Figure 3 of Section 3.5.
Redelmeier and Singh’s results were based on the first two methods in
Table 4, and Sylvestre et al.’s results were based on the last two methods in
Table 4. All of these four methods are biased.
In our simulation setting, past winning history affects future nominations,
and past nomination history also affects future winning. The previous meth-
ods did not account for the nomination history in the time-dependent Cox
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Table 4
Simulation results
Type of analysis Status Time-zero Mean of p-value
PH Static Birthday 0.03
PH Dynamic Birthday 0.12
PH Dynamic Nomination day 0.12
PY Dynamic Nomination day 0.04
model. Next we will show that even if one correctly models the effect of
nomination history on the hazard of death, the hazard model still provides
biased estimates of the causal effect of winning on survival.
To simplify the consideration of nomination history and winning history,
we restrict every candidate to be nominated at most twice and win at most
twice. Let D70 and D80 denote death at age 70 and 80, respectively. Let
S69 and S79 denote survival at age 69 and 79, respectively. Let N(30) and
N(60) denote the numbers of nominations in the age group 30–39 and 60–
69, respectively. Let A(30) and A(60) denote the numbers of wins in the age
group 30–39 and 60–69, respectively. Based on 1000 Monte Carlo simula-
tions, we obtained estimated mortality hazard rates and corresponding 95%
confidence intervals for this full model in Tables 5 and 6.
For a reduced model without winning history, the mortality rates just
adjusting the nomination history are shown in Table 7. From the above
probabilities, we can see even though winning has no causal effect on sur-
vival, winning history affects the hazard of death given nomination history,
for example, the hazard of dying at 80 for people with one nomination dur-
ing their 30s and no further nominations is much higher for people who did
not win an award (0.674) than for those who won one award (0.555).
Table 5
Mortality rates for death at 70 conditional on survival to
69 with nomination history and winning history when
nomination is affected by past winning history
Mortality rates
N(30) A(30) N(60) A(60) (95% CI)
2 2 0 0 0.355 (0.299, 0.411)
2 1 0 0 0.349 (0.332, 0.366)
2 0 0 0 0.327 (0.320, 0.334)
1 1 0 0 0.508 (0.494, 0.523)
1 0 0 0 0.407 (0.404, 0.410)
0 0 0 0 0.380 (0.378, 0.381)
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Table 6
Mortality rates for death at 80 conditional on survival to 79 with nomination history and
winning history when nomination is affected by past winning history
Mortality rates
N(30) A(30) N(60) A(60) N(70) A(70) (95% CI)
2 2 0 0 0 0 0.472 (0.401, 0.544)
2 1 0 0 0 0 0.511 (0.489, 0.534)
2 0 0 0 0 0 0.493 (0.484, 0.502)
1 1 0 0 0 0 0.555 (0.533, 0.577)
1 0 0 0 0 0 0.674 (0.669, 0.678)
1 1 1 1 0 0 0.474 (0.437, 0.511)
1 1 1 0 0 0 0.468 (0.444, 0.492)
1 0 1 1 0 0 0.191 (0.177, 0.206)
1 0 1 0 0 0 0.190 (0.184, 0.196)
0 0 1 1 0 0 0.439 (0.418, 0.460)
0 0 1 0 0 0 0.521 (0.514, 0.528)
0 0 2 2 0 0 0.137 (0.119, 0.155)
0 0 2 1 0 0 0.092 (0.087, 0.098)
0 0 2 0 0 0 0.039 (0.036, 0.041)
0 0 0 0 0 0 0.617 (0.615, 0.619)
If we consider a discrete time hazard model, the mortality rate can be
modeled as follows:
h=
1
1+ exp(−
∑
iαiZi)
,
where h is the mortality rate, and Zi is the indicator function of nomination
and winning history in the full model, or the indicator function of nomination
history in the reduced model. Then we can estimate the coefficients αi based
on the mortality rates calculated above. With this discrete time hazard
model, we can calculate the log likelihood of the full model and the reduced
model for each simulation round. Because
−2(loglikelihood (Reduced Model)− loglikelihood (Full Model))
D
→ χ212
when the reduced model is true, we can obtain approximate p-values for the
test of whether winning has an effect on mortality given nomination history.
If the mean of p-values is significantly different from 0.5, then it shows that
even if one has a correct model for the conditional hazard of death given all
the measured time-dependent confounding factors, the model still provides
a biased estimate of the effect of winning on survival.
The mean of p-values over 1000 simulation round is 0.404, showing that
there is bias. The histograms of p-values and test statistics are shown in
Figure 1.
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Table 7
Mortality rates conditional on nomination history when
nomination is affected by past winning history
Mortality rates
Death age N(30) N(60) N(70) (95% CI)
70 2 0 0.331 (0.324, 0.337)
70 1 0 0.413 (0.410, 0.416)
70 0 0 0.380 (0.378, 0.381)
80 2 0 0 0.495 (0.487, 0.503)
80 1 0 0 0.668 (0.664, 0.672)
80 1 1 0 0.227 (0.222, 0.232)
80 0 1 0 0.513 (0.506, 0.519)
80 0 2 0 0.059 (0.057, 0.062)
80 0 0 0 0.617 (0.616, 0.619)
In the above simulation setting, nomination history is both a confounder
for winning history’s effect on survival and has been affected by winning
history. We now show that if nomination history is only a confounder and has
not been affected by winning history, then the time-dependent Cox model
that controls for nomination history produces correct inferences. We keep
the same simulation set up as before, except that we change the selection
weights for age group 60–69 in Table 3 to the selection weights in Table 8.
We still restrict every candidate to be nominated at most twice and win
at most twice. Based on 1000 Monte Carlo simulations, we obtained esti-
mated mortality hazard rates for this full model in Table 9. For a reduced
Fig. 1. Histograms for p-values and test statistics from the likelihood ratio test of whether
winning has an effect on mortality given nomination history based on the discrete time
hazard model when the nomination is affected by past winning history.
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Table 8
Selection weight for age 60–69 when nomination
history is not affected by winning history
Previous winner Previous nonwinner
Group 1 0 0
Group 2 8 8
Group 3 9 9
model without winning history, the mortality rates just adjusting the nom-
ination history are shown in Table 10. From the probabilities in Tables 9
and 10, conditioning on the same nomination history, winning does not have
a significant effect on the mortality rates.
Similarly, based on the discrete time hazard model, the mean of p-values
in 1000 Monte Carlo simulations is 0.52, and the p-values and test statistics
of likelihood ratio test are shown in Figure 2. The simulation illustrates
that when nomination is not affected by the past winning history, a correct
time-dependent hazard model does not suffer from the healthy performer
survivor bias.
Table 9
Mortality rates conditional on nomination history and winning history when nomination
is not affected by past winning history
Death Mortality rates
age N(30) A(30) N(60) A(60) N(70) A(70) (95% CI)
70 2 2 0 0 0.317 (0.267, 0.368)
70 2 1 0 0 0.327 (0.310, 0.343)
70 2 0 0 0 0.337 (0.330, 0.344)
70 1 1 0 0 0.424 (0.411, 0.436)
70 1 0 0 0 0.425 (0.422, 0.429)
70 0 0 0 0 0.389 (0.388, 0.390)
80 2 2 0 0 0 0 0.514 (0.449, 0.578)
80 2 1 0 0 0 0 0.508 (0.486, 0.529)
80 2 0 0 0 0 0 0.494 (0.485, 0.503)
80 1 1 0 0 0 0 0.592 (0.574, 0.611)
80 1 0 0 0 0 0 0.575 (0.570, 0.580)
80 1 1 1 1 0 0 0.461 (0.418, 0.504)
80 1 1 1 0 0 0 0.483 (0.454, 0.513)
80 1 0 1 1 0 0 0.481 (0.464, 0.498)
80 1 0 1 0 0 0 0.480 (0.472, 0.487)
80 0 0 1 1 0 0 0.686 (0.674, 0.697)
80 0 0 1 0 0 0 0.688 (0.683, 0.693)
80 0 0 2 2 0 0 0.428 (0.396, 0.459)
80 0 0 2 1 0 0 0.453 (0.440, 0.465)
80 0 0 2 0 0 0 0.451 (0.444, 0.458)
80 0 0 0 0 0 0 0.559 (0.558, 0.561)
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Table 10
Mortality rates conditional on nomination history when
nomination is not affected by past winning history
Mortality rates
Death age N(30) N(60) N(70) (95% CI)
70 2 0 0.334 (0.328, 0.340)
70 1 0 0.425 (0.422, 0.428)
70 0 0 0.389 (0.388, 0.390)
80 2 0 0 0.499 (0.491, 0.507)
80 1 0 0 0.577 (0.572, 0.581)
80 1 1 0 0.480 (0.474, 0.487)
80 0 1 0 0.687 (0.682, 0.691)
80 0 2 0 0.451 (0.445, 0.457)
80 0 0 0 0.559 (0.558, 0.561)
3. Rank preserving structural accelerated failure time model. Robins
(1986, 1992) and Robins et al. (1992) recognized the potential of conven-
tional time-dependent proportional hazard models to provide biased esti-
mates of causal effects when there are healthy performer survivor effects
(Robins called these healthy worker effects). Robins (1986) was particularly
concerned with occupational mortality studies in which unhealthy workers
who terminate employment early are at an increased risk of death compared
to other workers and receive no further exposure to the chemical agent under
study. More generally, Robins has shown that the usual time-dependent Cox
proportional hazards model approach might be biased when “(a) there exists
a time-dependent risk factor for, or predictor of, the event of interest that
Fig. 2. Histograms for p-values and test statistics from the likelihood ratio test of whether
winning has an effect on mortality given nomination history based on the discrete time
hazard model when the nomination is not affected by past winning history.
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also predicts subsequent treatment and (b) past treatment history predicts
subsequent risk factor level.” In our context (a) nomination history is a time-
dependent risk factor for death and a predictor of winning subsequent Oscar
Awards, and (b) past winning history predicts future nomination. Robins de-
veloped the rank preserving structural accelerated failure time model with
g-estimation to eliminate bias from the time-dependent Cox proportional
hazards model under conditions (a) and (b) above. We will adapt Robins’
rank preserving structural accelerated failure time model and g-estimation
method.
Our key assumption is as follows:
Assumption 1 (Randomization assumption). Conditional on age, pre-
vious nominations, and previous wins, the winner of an Oscar Award in each
year is selected randomly among nominees for that award.
We make no assumption about the nominees being randomly selected
from the pool of actors and actresses, only that the winner is randomly cho-
sen (conditional on covariates) among the nominees. Indeed, some pundits
suggest that being nominated for an Oscar Award is due to talent, whereas
winning one is due to luck [Sylvestre, Huszti and Hanley (2006)]. Gehrlein
and Kher (2004) provide further discussion of Oscar Award selection proce-
dures.
3.1. Basic setup. We focus on the causal effect of winning an Oscar
Award for the first time on a performer’s survival, and do not consider any
additional effect of multiple wins here. We focus only on comparing winners
to nonwinning nominees.
To simplify our discussion, we use candidate (i, j) to denote a candidate j
who has been nominated for the ith Oscar Award. There are a total of 300
Oscar Awards in our data, so i= 1,2, . . . ,300. We assume the existence of a
latent or potential failure time variable Ui,j , which represents the potential
years candidate (i, j) would live after the award date if he or she did not win
an Award on date i nor in the rest of his or her lifetime. However, we only
observe the observed failure time variable Ti,j , which means the observed
years candidate (i, j) lives after the award date until his or her death. We
will assume that the Ti,j are uncensored until Section 3.4, where we will
consider censoring.
3.2. Rank preserving structural accelerated failure time model. The rank
preserving structural accelerated failure time model (RPSAFTM) assumes
that winning an Oscar for the first time multiplies a performer’s remaining
lifetime by a treatment effect factor exp(−ψ). The parameter ψ is the addi-
tive effect of winning on the log of a performer’s remaining lifetime after the
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award. A positive ψ means winning decreases lifetime, a negative ψ means
winning increases lifetime and ψ = 0 means winning has no effect. See Cox
and Oakes (1984) and Robins (1992) for more discussion of the accelerated
failure time model.
For the RPSAFTM, the potential failure time Uij can be calculated from
the observed failure time Tij as follows. Let Fi,j be the first time candidate
(i, j) won an Oscar Award (Fi,j =∞ if the candidate never won an Award),
andDi be the date of the ith Oscar Award. Let set A contain candidates who
never won an Oscar Award in their whole lifetime, set B contain candidates
who won Oscar Awards at least once and for whom Fi,j < Di, and set C
contain candidates who won Oscar Awards at least once and for whom
Fi,j ≥Di. We have
Ui,j =


Ti,j, if candidate (i, j) ∈A∪B,
Fi,j −Di
+ exp(ψ)(Ti,j +Di −Fi,j), if candidate (i, j) ∈C.
(1)
As an example, consider Marlon Brando who was born on April 3, 1924,
and died on July 1, 2004. Brando was nominated for an Oscar for the first
time on March 20, 1952 (i= 77), but did not win the Award. He won two
Oscar Awards in his career: the first time on March 30, 1955 (i = 89) and
the second time on April 27, 1973 (i = 161). His information is listed in
Table 11.
U77,B(ψ) = (30Mar55− 20Mar52) + exp(ψ)(1Jul04− 30Mar55),
U81,B(ψ) = (30Mar55− 19Mar53) + exp(ψ)(1Jul04− 30Mar55),
U85,B(ψ) = (30Mar55− 25Mar54) + exp(ψ)(1Jul04− 30Mar55),
U89,B(ψ) = exp(ψ)(1Jul04− 30Mar55),
U101,B(ψ) = 1Jul04− 26Mar58,
U161,B(ψ) = 1Jul04− 27Apr73,
U165,B(ψ) = 1Jul04− 2Apr74,
U231,B(ψ) = 1Jul04− 26Mar90.
The subscript “B” represents Marlon Brando. Note that in the RPSAFTM
(1), Brando’s multiple wins have no additional effect on his survival beyond
his first win.
3.3. Test of treatment effect on survival. Although the latent failure time
variable Ui,j can be calculated based on the treatment effect factor ψ, ψ is
still an unknown parameter that we need to estimate. The basic idea for
testing the plausibility of a hypothesized treatment effect under Assump-
tion 1 is the following: if the hypothesized treatment effect is correct, the
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Table 11
Marlon Brando’s nominations
Nomination date Number of award (i) Award Win
20Mar52 77 Best Actor N
19Mar53 81 Best Actor N
25Mar54 85 Best Actor N
30Mar55 89 Best Actor Y
26Mar58 101 Best Actor N
27Apr73 161 Best Actor Y
2Apr74 165 Best Actor N
26Mar90 231 Best Supporting Actor N
latent failure times in the treatment (winning) and control (nonwinning)
groups should be similar, but if the hypothesized treatment effect is too
large (small), the latent failure times in the treatment group will tend to be
smaller (larger) than those in the control group.
To explain the details, let Ai,j denote the treatment status for candida-
te (i, j):
Ai,j =
{
1, if candidate (i, j) wins the ith award,
0, if candidate (i, j) loses the ith award.
Note that Ai,j is only defined if j was nominated for the ith award. Let Wi,j
denote the vector of candidate (i, j)’s covariates, such as age at time of
nomination, number of previous nominations, and number of previous wins,
etc. Note that some of the covariates in Wij can be time dependent.
Let Uij(ψ0) denote the latent failure time if ψ0 is the true treatment
effect; Uij(ψ0) can be calculated from (1). Consider a logistic regression
model for the probability that candidate (i, j) wins award i conditional on
Wij and Uij(ψ0):
P (Aij = 1|Wij ,Uij(ψ0))
(2)
=
exp(βWij + θ(ψ0)Uij(ψ0))
1 + exp(βWij + θ(ψ0)Uij(ψ0))
,
where β and θ(ψ0) are unknown parameters. We use conditional logis-
tic regression for estimating (2), where we condition on there being one
winner among the nominees for each award. Only the nominees for each
award are considered in the conditional logistic regression, that is, the can-
didates included in the regression are (i, j1), . . . , (i, jni), where i= 1, . . . ,300,
and j1, . . . , jni are the nominees for the ith award (ni = 5 except for some
early awards). See the last two paragraphs of this section for discussion
of a modification of this conditional logistic regression that improves ef-
ficiency. Model (2) combined with conditioning on there being one win-
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ner for each award is equivalent to the model that the winner of award i
is determined according to McFadden’s (1974) choice model where (Wij1 ,
Uij1(ψ0)), . . . , (Wijni ,Uijni (ψ0)) are the covariates that describe the ni choices
for the award.
For the true ψ, the coefficient θ(ψ) on Uij(ψ) in (2) should equal zero.
This is because under Assumption 1, conditional on the covariates Wij ’s of
the nominees for an award, the latent failure times Uij ’s of the nominees are
independent of which nominee wins the award, that is,
P (Aij = 1|Wij ,Uij) = P (Aij = 1|Wij).
We test the null hypothesis that ψ equals a particular value ψ0 by seeing
whether a score test accepts or rejects the null hypothesis that the true value
of θ(ψ) is 0. In other words, we test
H10 :ψ = ψ0 vs. H1a :ψ 6= ψ0
by testing
H20 : θ(ψ0) = 0 vs. H2a : θ(ψ0) 6= 0.
Rejection of H20 implies rejection of H10, and acceptance of H20 implies
acceptance of H10. We invert this test to find a confidence interval for ψ,
that is, the 95% confidence interval consists of all ψ0 for which we do not
reject H20.
We now discuss an efficiency issue for testing ψ = ψ0. If a candidate (i, j)
has already won an award before the date of the ith Oscar Award, then
Tij = Uij regardless of whether the candidate wins the award at the date of
the ith Oscar Award. Candidate (i, j) contributes no information for testing
ψ = ψ0 since Uij(ψ0) is a constant function of ψ0. Consequently, it is more
efficient for testing ψ = ψ0 to not include candidates (i, j) in the analysis
who have already won an award before the date of the ith Oscar Award.
In fact, we found that for the Oscar data, the confidence interval based on
excluding candidates who have already won an award was 20% shorter than
the confidence interval based on including the already winners.
As an example of excluding the already winner candidates, for Marlon
Brando, we do not include (101,B), (161,B), (165,B), (231,B) because
Brando won the 89th Oscar Award (see Table 7). Because we estimate (2)
using conditional logistic regression in which we condition on the number of
winners for each award, by dropping candidates (i, j) who have already won
an award before award i, we effectively drop all data from awards in which
the winner had already won an award before.
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3.4. Censoring case. If the lifetimes for all candidates were observed and
Assumption 1 holds, the above analysis would provide consistent tests for the
treatment effect. However, if some of the lifetimes are censored and we treat
the censored lifetime as the observed lifetime, there will be a violation of
Assumption 1. Let Ci,j denote the censoring time of candidate (i, j). For our
data, Ci,j = July 25, 2007 for all i, j. Instead of observing the failure time Tij
of how long candidate j lives after the date Di of award i, we observe the
censored failure time Xij =min(Tij ,Cij −Di). Consider the variable U
∗
i,j(ψ)
that is generated by substituting Xi,j for Ti,j in the RPSAFTM (1) to cal-
culate Ui,j . If ψ 6= 0, then U
∗
ij(ψ) is not independent of Aij given Wij . To
illustrate this, we provide the following example. Suppose there is a posi-
tive treatment effect for winning an Oscar Award on performers’ survival.
Consider a candidate A who just won once in his whole career. Suppose he
won on date D. Assume his actual remaining lifetime after D is T . If there
is a positive treatment effect, his latent failure time value will be U where
U < T . When the censoring time C satisfies U <C−D< T , the correspond-
ing U∗(ψ) generated by substituting C −D for T in the RPSAFTM will be
smaller than U for the true ψ. Now consider a candidate B who has the same
latent failure time U and the same censoring time C as candidate A, but
who never won any awards. For candidate B, we have U∗(ψ) = U . Hence, for
these two candidates with identical U ’s, winning is associated with U∗(ψ).
In summary, when there is a positive treatment effect, winning an Oscar
Award will prolong performers’ lifetime, making latent failure times more
likely to get censored compared to nonwinning nominees, and causing bias
if censored failure times are treated as actual failure times.
In the above example, if we want to have the same censored latent failure
time for both winning and losing performers who have the same actual latent
failure time, we can modify the censoring time for the losing performer to
be before the actual censoring time so that U∗(ψ) will be censored in the
same way regardless of whether a performer wins or loses. This is Robins et
al.’s (1992) idea of artificial censoring.
We define an observable variable U∗∗i,j (ψ0) that is a function of (Ui,j(ψ0),
Ai,j) and use it as a basis for inference concerning ψ0. U
∗∗
ij (ψ0) is defined
by censoring Uij(ψ0) at the artificial censoring time Cij(ψ0) that is defined
below.
Recall that Fij is candidate (i, j)’s first win time, and Di is the date of ith
Oscar Award.
When Fij ≥Di,
Ci,j(ψ0) = min((Ci,j −Di), (Ci,j −Di) exp(ψ0)).
When Fij <Di,
Ci,j(ψ0) =Cij −Di.
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Table 12
Simulation results
Type of analysis Status Time-zero Mean of p-value
PH Static Birthday 0.03
PH Dynamic Birthday 0.12
PH Dynamic Nomination day 0.12
PY Dynamic Nomination day 0.04
RPSAFTM Dynamic Nomination day 0.49
Then U∗∗i,j (ψ0) = min(Ui,j(ψ0),Ci,j(ψ0)). We substitute U
∗∗
i,j (ψ0) for
Ui,j(ψ0) in the conditional logistic regression model (2), and test the null
hypothesis θ(ψ0) = 0. Note that U
∗∗
ij (ψ0) could be any observable function
of Uij(ψ0),Cij(ψ0), not just min(Uij(ψ0),Cij(ψ0)). Robins (1993) describes
the semiparametric efficient such function.
3.5. Simulation results. In Section 2.4 our simulation study showed that
previous studies suffered from healthy performer survivor bias. Here we will
use the same setup to test the RPSAFTM. Recall that a correct analysis
method should produce approximately uniformly distributed p-values in the
simulation study. The results in Table 12 are from 1000 simulations. We
have shown the first four rows from the simulations in Section 2.4 (Table 4),
and add the last row for the RPSAFTM.
Figure 3 contains histograms for p-values of the five methods from 1000
simulations.
Fig. 3. Histograms for p-values from the test of whether winning has an effect on mor-
tality based on the four methods of previous studies and the RPSAFTM introduced by the
current paper.
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In the first four plots, the majority of the p-values are smaller than 0.2,
while in the last plot, the p-values are uniformly distributed. The RPSAFTM
corrects the survivor treatment selection bias that previous methods suffer
from.
4. Analysis of Oscar Award data. We have compiled a data file that
records the nominees and winners for each award (best lead actor, best
lead actress, best supporting actor, best supporting actress) on each Os-
car Award date. We collected the data from www.imdb.com. The data is
in the supplementary materials [Han et al. (2010)]. The selection inter-
val spanned from the inception of the Oscar Awards to July 25, 2007. In
computing lifetime since being nominated, we use the actual Oscar Award
date which varies from year to year. People who were not reported dead on
www.imdb.com were presumed to be alive. There are 260 winners and 564
nonwinning nominees, 824 performers in all. Of these 824 performers, 448
are censored.
We did not include several candidates in our data set. Margaret Avery
was nominated for best supporting actress in 1985, but we could not find
her birthday and day of death from the internet. We did not include the
following candidates who died before the winner of the award for which
they were nominated was announced: Massimo Troisi, Jeanne Eagels, James
Dean, Spencer Tracy, Peter Finch, and Ralph Richardson.
We have shown results from previous studies, which are based on less
years of Oscar data than ours, in Table 1. To compare previous studies
with ours, we have applied the methods of previous studies to our updated
Oscar Award data set; the results are shown in Table 13. Compared with the
results in Table 1, the reductions in mortality rate in Table 13 are smaller.
The confidence intervals are also narrower, because we have 7 years more
candidates than the original data set, and also each candidate in our data
set has 7 years more information.
Table 13
Winners vs. nominees
Reduction in
mortality rate
Type of analysis Status Time-zero (95% CI) (%)
PH Static Birthday 19 (6 to 31)
PH Dynamic Birthday 9 (−6 to 22)
PH Dynamic Nomination day 14 (0 to 26)
PY Dynamic Nomination day 10 (−6 to 23)
PH2 Dynamic Nomination day 8.7 (−7.3 to 24.7)
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Table 14
Summary of conditional logistic model
coef exp(coef) se(coef) z p-value
U∗∗ij (0) 1.37e−02 1.01 0.007541 1.812 0.07
nomage 5.36e−02 1.06 0.101676 0.527 0.60
nomage.square −9.18e−04 1.00 0.002278 −0.403 0.69
nomage.cubic 7.40e−06 1.00 0.000016 0.462 0.64
numprenom 6.99e−02 1.07 0.071407 0.979 0.33
In Table 8 the first four rows are based on previous methods. We also add
the fifth row, which corresponds to a Cox time-dependent model adjusting
for past nomination history and winning history; nomination history is ad-
justed for by conditioning on the number of previous nominations. Note that
previous methods did not consider the nomination history.
We now consider fitting the RPSAFTM. For the conditional logistic re-
gression (2), we use the following time dependent covariates Wij : age of
nomination (nomage), square of age of nomination (nomage.square), cube
of age of nomination (nomage.cubic), and number of previous nominations
(numprenom). Table 14 shows the results of the conditional logistic regres-
sion model (2) when ψ = 0.
The p-value for the test of whether the coefficient on U∗∗ij (0) is 0, that is,
the test of H20 : θ(0) = 0 vs. H2a : θ(0) 6= 0, is 0.07. Thus, we do not reject the
null hypothesis that winning an Oscar has no effect on a performer’s survival
at the 0.05 level. Looking at the effect of the other covariates (the Wij) in
Table 14, there is not strong evidence that number of previous nominations
has an effect on the probability of a performer winning. For age at time of
nomination, although the p-values on each of the polynomial terms are not
significant, a test that the coefficient on all three of the terms is zero gives
a p-value of 0.03 so age at time of nomination does appear to affect winning.
Older nominees are slightly more likely to win.
The validity of our test of the effect of winning an Oscar depends critically
on correctly controlling for the effect of age at time of nomination on winning
since this age is clearly correlated with Uij (older nominees generally live
a shorter time after the award date, so have smaller Uij ’s). To check that
our results are robust to different ways of controlling for age at time of
nomination, we replaced the cubic polynomial in nomage in Table 10 with
a cubic spline of nomage with 1 to 4 knots placed at equally spaced quantiles.
The p-values for the test of H20 : θ(0) = 0 vs. H2a : θ(0) 6= 0 ranged from 0.064
to 0.07 in these analyses. Thus, our result that there is not evidence that
winning has an effect on survival at the 0.05 level is robust to how nomage
is controlled for. We will use the cubic polynomial for nomage in Table 14
in our subsequent discussion.
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Table 15
95% confidence interval for treatment effect
Treatment effect CI
ψ [−0.2360,0.0088]
Winning multiplies survival
exp(−ψ) [0.9912,1.2662]
Table 15 shows the 95% confidence interval for the treatment effect. Our
95% confidence interval is that the effect of winning is in the range of de-
creasing survival (after the award date) by 0.88% to increasing survival by
26.62%.
Robins’ g-estimate for the treatment effect is the ψ0 that makes θ̂(ψ0) = 0
in the conditional logistic regression (2). This ψ0 maximizes the p-value for
testing H20 : θ(ψ0) = 0 vs. H2a : θ(ψ0) 6= 0. Robins et al. (1992) show that the
g-estimate is asymptotically normal and consistent. The g-estimate can also
be viewed as the Hodges–Lehmann (1963) estimate of the treatment effect
based on the test of H20 : θ(ψ0) = 0.
We search for possible values of ψ0 with θ̂(ψ0) = 0 in the range [−0.2360,
0.0088] with step size = 0.0001. Figure 4 shows the estimates θ̂(ψ0) and the
p-values for testing H20 : θ(ψ0) = 0. θ̂(ψ) is a monotone increasing function
of ψ in [−0.2360,0.0088]. The g-estimate is ψ̂ =−0.1127, which corresponds
to winning increasing survival by 12%. To estimate the survival advantage
for winners in terms of years, we consider the performers who won the first
time they were nominated. For these performers, we find their censored
latent failure time U∗∗ij (ψ̂) under the assumption that the point estimate ψ̂
of ψ is the true treatment effect. Then we make Kaplan–Meier estimates for
Fig. 4. Estimate of the coefficient θ of the modified potential failure time variable U∗∗ij (ψ)
in the conditional logistic regression (2) for different treatment effect value ψ and p-values
from the test of whether θ(ψ) equal zero for different ψ.
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the distribution of the actual survival times for these winners and for the
distribution of the latent survival times if these winners had never won. The
difference between the estimated medians of these two distributions is an
estimate of the survival advantage of winning the award for these winners.
In the current Oscar Award data, we estimate the survival advantage to be
4.2 years, with a 95% confidence interval of [−0.4,8.4] years.
4.1. Diagnostic plots. To examine whether the RPSAFTM is appropri-
ate for the Oscar Award data set, we use boxplots to check if the randomiza-
tion assumption (Assumption 1) is violated for latent failure times computed
according to the RPSAFTM at our point estimate ψ̂ of ψ. This is similar to
the diagnostics for testing an additive treatment effect model in Small et al.
(2006). Based on the randomization assumption, for the point estimate ψ̂,
the distributions of U∗∗ij (ψ̂) should be approximately the same for the treat-
ment group (winners) and the control group (nonwinning nominees) in the
same range of nomage. We divide the candidates into five subgroups based
on the quantiles of nomage. For each subgroup, we make boxplots for U∗∗ij (ψ̂)
for the winners and the nonwinning nominees. Figure 5 shows the distribu-
tion of U∗∗ij (ψ̂) is similar among winners and nonwinning nominees for each
range of nomage. This supports the validity of the RPSAFTM (assuming
that Assumption 1 is valid).
Fig. 5. Boxplots of U∗∗ij (ψ̂) for comparison between treatment group (winners) and con-
trol group (nonwinning nominees) in five subgroups based on the quantiles of nomage.
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Table 16
Sensitivity analysis
exp(10θ∗) =
Odds ratio for two Survival advantage
otherwise equal people in terms of years
one has 10 years point estimate/
higher U∗∗ij than other θ
∗ Confidence interval for ψ confidence interval
0.5 −0.0693 (−0.6587,−0.4174) 16.4/(13.6,19.3)
0.6 −0.0511 (−0.5652,−0.3235) 14.1/(11.0,17.2)
0.7 −0.0357 (−0.4769,−0.2374) 11.7/(8.4,15.1)
0.8 −0.0223 (−0.3911,−0.1550) 9.3/(5.7,12.9)
0.9 −0.0105 (−0.3100,−0.0730) 6.8/(2.8,10.6)
1 0 (−0.2360,0.0088) 4.2/(−0.4,8.4)
1.1 0.0095 (−0.1654,0.0879) 1.4/(−3.7,6.1)
1.2 0.0182 (−0.0940,0.1697) −1.5/(−6.9,3.6)
1.3 0.0262 (−0.0210,0.2515) −4.4/(−10.9,0.8)
1.4 0.0336 (0.0413,0.3359) −7/(−16.4,−1.3)
1.5 0.0405 (0.0985,0.4238) −10.3/(−19.2,−4.2)
4.2. Sensitivity analysis. Our basic assumption, Assumption 1, is that,
conditional on covariates such as age at nomination, and number of pre-
vious nominations, who wins the Oscar Award is not related to how long
the candidates would have lived without winning an award. This could be
violated if performers who lead a more healthy lifestyle are more likely to
win or if performers who lead a more reckless lifestyle are more likely to win.
We now provide a sensitivity analysis to violations of Assumption 1. Under
Assumption 1, θ(ψ) is 0. If Assumption 1 is violated, then θ(ψ) = θ∗ 6= 0.
For θ(ψ) = θ∗, we can test the plausibility of ψ0 by testing H
′
20 : θ(ψ0) = θ
∗
vs. H ′2a : θ(ψ0) 6= θ
∗. To calibrate θ∗, we note that we can interpret exp(10θ∗)
as the odds ratio for one candidate to win compared to another, if the one
candidate has a ten year higher latent failure time than the other and the
two candidates are the same age at nomination and have the same number of
previous nominations. Under Assumption 1, exp(10θ∗) = 1. Table 16 shows
confidence intervals for ψ and the survival advantage of winning for winners
at first nomination for different values of θ∗.
As the odds ratio exp(10θ∗) increases from 0.5 to 1.5, the point esti-
mate of the survival advantage decreases from 16.4 years to −10.3 years.
If less healthy candidates are moderately more likely to win than healthy
candidates, exp(10θ∗) = 0.9, then the confidence interval only contains neg-
ative ψ, and there is strong evidence that winning increases survival. But if
more healthy candidates are somewhat more likely to win than less healthy
candidates, exp(10θ∗) = 1.2, then the confidence interval contains predomi-
nantly positive ψ and the point estimate is that winning decreases survival.
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5. Discussion. In this paper we point out that healthy performer survivor
bias exists in methods from previous studies of the effect of winning an Oscar
on survival. We show that under Assumption 1 (among nominees, the winner
is randomly selected conditional on baseline covariates), Robins’ RPSAFTM
eliminates healthy performer survivor bias. We estimated that the effect of
winning an Oscar Award on survival for winners at first nomination is to
increase survival by 4.2 years, but the 95% confidence interval of [−0.4,8.4]
years contains negative effects. Thus, our study indicates that there is not
strong evidence that winning an Oscar increases life expectancy.
The analysis in this paper is a case study of how Robins’ RPSAFTM can
provide an improvement over Cox proportional hazards models for estimat-
ing the effect on survival of a sudden change in a person’s life, for example,
becoming ill, starting a high risk behavior, or starting a treatment. A key
assumption (our Assumption 1) that is needed to obtain inferences from the
RPSAFTM is that, conditional on covariates recorded up to a given time, the
sudden change is “randomly” assigned. A feature of our application, unlike
most other applications of RPSAFTMs [e.g., Robins et al. (1992); Herna´n et
al. (2005)], is that we only assume the sudden change is randomly assigned
among a select subset of the people in the study rather than all people in the
study. In particular, we are only assuming that among nominees in a given
year, who are generally at least somewhat healthy in the given year, the win-
ner is randomly selected. We are not assuming that the winner is randomly
selected from the pool of all actors and actresses who have been nominated
in a previous year or the given year and are still alive. Some performers nom-
inated in a previous year might be too unhealthy to act even though they
are still alive. Similar consideration of comparability only among a selected
subset can be found in Joffe et al. (1998) and Robins (2008).
In the RPSAFTM, model (1) is rank preserving, that is, the effect of
winning is the same for each subject. Robins et al. (1992) and Lok et al.
(2004) discussed an expanded class of SAFTMs, which does not need the
RHS of (1) at the true ψ to be equal to the actual counterfactual failure
time Uij , rather it just needs that the RHS and the Uij have the same
distribution conditional on past measured covariates sufficient to control
confounding. This eliminates the assumption of rank preservation without
changing the method of estimation of the population (i.e., distributional)
interpretation of ψ.
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SUPPLEMENTARY MATERIAL
Supplement A: Oscar Award data for actors and actresses
(DOI: 10.1214/10-AOAS424SUPPA; .dat). We have compiled a data file that
records the nominees and winners for each award (best lead actor, best lead
actress, best supporting actor, best supporting actress) on each Oscar Award
date. We collected the data from www.imdb.com. The selection interval
spanned from the inception of the Oscar Awards to July 25, 2007.
Supplement B: R code for data analysis and simulation
(DOI: 10.1214/10-AOAS424SUPPB; .zip). We provide the R code for our
data analysis and simulation studies. File “R code.txt” is for preprocessing
the Oscar data and data analysis in Section 4. File “simulation 1.txt” is for
the simulation studies in Sections 2.4 and 3.5, especially for Tables 4, 12, and
Figure 3. File “simulation 2.txt” is for the simulation studies in Tables 5–10
and Figures 1 and 2.
REFERENCES
Abel, E. L. andKruger, M. L. (2005). The longevity of Baseball hall of famers compared
to other players. Death Studies 29 959–963.
Cox, D. R. andOakes, D. (1984). Analysis of Survival Data. Chapman and Hall, London.
MR0751780
Efron, B. (2002). The two-way proportional hazards model. J. R. Stat. Soc. Ser. B Stat.
Methodol. 64 899–909. MR1979394
Ferrie, J. E., Shipley, M. J., Davey, S. G., Stansfeld, S. A. and Marmot, M. G.
(2002). Change in health inequalities among British civil servants: The Whitehall II
study. Journal of Epidemiology and Communitiy Health 56 922–926.
Gehrlein, W. V. and Kher, H. V. (2004). Decision rules for the Academy Awards versus
those for elections. Interfaces 34 226–234.
Han, X., Small, D., Foster, D. and Patel, V. (2010). Supplement to “The ef-
fect of winning an Oscar Award on survival: Correcting for healthy performer sur-
vivor bias with a rank preserving structural accelerated failure time model.” DOI:
10.1214/10-AOAS424SUPPA, DOI: 10.1214/10-AOAS424SUPPB.
Herna´n, M. A., Cole, S. R., Margolick, J. B., Cohen, M. H. and Robins, J. M.
(2005). Structural accelerated failure time models for survival analysis in studies with
time-varying treatments. Pharmacoepidemiology and Drug Safety 14 477–491.
Hodges, J. L. and Lehmann, E. L. (1963). Estimates of location based on rank tests.
Ann. Math. Statist. 34 598–611. MR0152070
Joffe, M. M., Hoover, D. R., Jacobson, L. P., Kingsley, L., Chmiel, J. S., Viss-
cher, B. R. and Robins, J. M. (1998). Estimating the effect of zidovudine on Kaposi’s
Sarcoma from observational data using a rank preserving structural failure-time model.
Stat. Med. 17 1073–1102.
Lok, J., Gill, R., Van Der Vaart, A. and Robins, J. (2004). Estimating the causal
effect of a time-varying treatment on time-to-event using structural nested failure time
models. Statist. Neerlandica 58 271–295. MR2157006
Marmot, M. G., Davey, S. G., Stansfeld, S., Patel, C., North, F., Head, J.,
White, I., Brunner, E. and Feeney, A. (1991). Health inequalities among British
civil servants: The Whitehall II study. Lancet 337 1387–1393.
SURVIVAL IN OSCAR AWARD WINNING PERFORMERS 27
Marmot, M. G., Rose, G. and Hamilton, P. J. S. (1978). Employment grade and
coronary heart disease in British civil servants. Journal of Epidemiology and Community
Health 32 244–249.
Marmot, M. G., Shipley, M. J. and Rose, G. (1984). Inequalities in death—specific
explanations of a general pattern? Lancet 323 1003–1006.
McFadden, D. (1974). Conditional logit analysis of qualitative choice behavior. In Fron-
tiers in Econometrics (P. Zarembka, ed.) 105–142. Academic Press, New York.
Rablen, M. D. and Oswald, A. J. (2008). Mortality and immortality: The Nobel Prize
as an experiment into the effect of status upon longevity. Journal of Health Economics
27 1462–1471.
Redelmeier, D. A. and Singh, S. M. (2001). Survival in Academy Award—winning
actors and actresses. Ann. Intern. Med. 134 955–962.
Reid, D. D., Brett, G. Z., Hamilton, P. J. S., Jarrett, R. J., Keen, H. and
Rose, G. (1974). Cardio-respiratory disease and diabetes among middle-aged male
civil servants: A study of screening and intervention. Lancet 303 469–473.
Robins, J. M. (1986). A new approach to causal inference in mortality studies with
a sustained exposure period—applications to control of the healthy worker survivor
effect. Math. Model. 7 1393–1512. MR0877758
Robins, J. M. (1992). Estimation of the time-dependent accelerated failure time model
in the presence of confounding factors. Biometrika 79 321–334. MR1185134
Robins, J. M. (1993). Analytic methods for estimating HIV treatment and cofactor effects.
In Methodological Issues of AIDS Mental Health Research 213–290. Plenum Publishing,
New York.
Robins, J. M. (2008). Causal models for estimating the effects of weight gain on mortality.
International Journal of Obesity 32 S15–S41.
Robins, J. M., Blevins, D., Ritter, G. and Wulfson, M. (1992). g-estimation of the
effect of prophylaxis therapy for pneumocystis carinii pneumonia on the survival of
AIDS patients. Epidemiology 3 319–336.
Sapolsky, R. (2005). The influence of social hierarchy on primate health. Science 308
648–652.
Small, D., Gastwirth, J., Krieger, A. and Rosenbaum, P. (2006). R-estimates vs.
GMM: A theoretical case study of validity and efficiency. Statist. Sci. 21 363–375.
MR2339136
Sylvestre, M. P., Huszti, E. and Hanley, J. A. (2006). Do Oscar winners live longer
than less successful peers? A reanalysis of the evidence. Ann. Intern. Med. 145 361–363.
X. Han
Department of Operations Research
and Financial Engineering
Princeton University
Room 214, Sherrerd Hall
Princeton, New Jersey 08544
USA
E-mail: xhan@princeton.edu
D. S. Small
D. P. Foster
V. Patel
Department of Statistics
Wharton School
University of Pennsylvania
400 Jon M. Huntsman Hall
3730 Walnut St.
Philadelphia, Pennsylvania 19104-6340
USA
E-mail: dsmall@wharton.upenn.edu
dean@foster.net
vvp@wharton.upenn.edu
